跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APRETUDE 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
APRETUDE 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
APRETUDE 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Viiv Healthcare B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 22, 2023
Approval ID
0cebed32939495e9
Company
Viiv Healthcare B.V.
Type
Standard
Approval Details
Approval Id
0cebed32939495e9
Drug Cima Aemps Name
APRETUDE 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
1231760001
Holder Company Name
Viiv Healthcare B.V.
Marketing Company Name
Laboratorios Viiv Healthcare S.L.
Holder Company Detail Path
/organization/viiv-healthcare-bv
Authorization Date
2023-09-22
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
30 MG
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Viiv Healthcare B.V.
Company Detail Path
/organization/viiv-healthcare-bv
Company Information
Pharmaceutical Company Name
ViiV Healthcare BV
Country Name
Netherlands
Website
http://viivhealthcare.com/nl-nl
Active Ingredients
CABOTEGRAVIR SODIO
31,62 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 22, 2023
Approval ID
0cebed32939495e9
Type
Standard
Back to CIMA-AEMPS Approvals
